MCOA: AI 评分 42/100 — AI 分析 (4月 2026)

Marijuana Company of America, Inc. develops and distributes cannabis and CBD products under the hempSMART brand. The company targets the wellness market with a range of products available through its website and affiliate programs.

Key Facts: AI Score: 42/100 Sector: Healthcare

公司概况

概要：

Marijuana Company of America, Inc. focuses on developing and distributing cannabis and CBD products under the hempSMART brand, targeting the wellness market through online and affiliate channels, while facing significant challenges in profitability and market competition within the specialty drug manufacturing sector.

MCOA是做什么的？

Marijuana Company of America, Inc. (MCOA) was founded in 1985 as Converge Global, Inc., before rebranding in December 2015 to capitalize on the emerging cannabis and CBD market. The company develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand within the United States. MCOA's product line includes hempSMART Brain, a patented personal care product for brain wellness; hempSMART Pain capsules and cream for discomfort relief; hempSMART Drops, a hemp CBD oil tincture; hempSMART Pet Drops for cats and dogs; hempSMART Face, a facial moisturizer; and hempSMART drink mix, a powderized CBD drink. These products are primarily sold through the company's website and affiliate marketing programs. Additionally, MCOA distributes hemp and CBD products, including smoke and vape shop related items, to wholesalers, c-stores, specialty retailers, and consumers through its cdistro.com platform. Headquartered in Los Angeles, California, MCOA aims to establish a presence in the growing CBD and cannabis wellness market.

MCOA的投资论点是什么？

Investing in Marijuana Company of America, Inc. presents significant risks due to its negative profitability and high beta of 9.91, indicating extreme volatility relative to the market. The company's negative profit margin of -1441.1% and gross margin of -74.1% raise concerns about its financial sustainability. Growth depends on successful expansion of the hempSMART product line and effective marketing strategies to increase sales through online and affiliate channels. Potential investors should carefully consider the risks associated with OTC-listed companies and the competitive landscape of the cannabis and CBD market. The company's small size, with only 7 employees, also poses operational challenges.

MCOA在哪个行业运营？

Marijuana Company of America, Inc. operates in the rapidly evolving cannabis and CBD market, which is characterized by increasing consumer demand for wellness products. The industry is highly competitive, with numerous companies vying for market share. MCOA faces competition from established players and emerging brands. The regulatory landscape is complex and varies by state, creating both opportunities and challenges for companies in this sector. The global cannabis market is projected to reach significant growth in the coming years, driven by increasing legalization and acceptance of cannabis and CBD products.

Drug Manufacturers - Specialty & Generic

Healthcare

MCOA有哪些增长机遇？

Expansion of hempSMART Product Line: MCOA has the opportunity to expand its hempSMART product line to cater to a broader range of consumer needs. By introducing new formulations and delivery methods, such as edibles or topicals, MCOA can attract new customers and increase sales. The global CBD market is projected to reach $16 billion by 2028, providing a substantial market opportunity for MCOA to capitalize on. This expansion requires investment in research and development and effective marketing strategies.
Strategic Partnerships and Distribution Agreements: MCOA can pursue strategic partnerships and distribution agreements to expand its reach and access new markets. Collaborating with established retailers or distributors can provide MCOA with access to a wider customer base and increase brand awareness. The company can also explore partnerships with healthcare providers or wellness centers to promote its products. These partnerships can be established within the next 1-2 years, driving revenue growth and market penetration.
International Expansion: MCOA can explore international expansion opportunities in countries where cannabis and CBD products are legal. By entering new markets, MCOA can diversify its revenue streams and reduce its reliance on the U.S. market. The European CBD market, for example, is experiencing rapid growth, presenting a significant opportunity for MCOA. This expansion will require careful consideration of regulatory requirements and market dynamics in each country.
Focus on E-commerce and Digital Marketing: MCOA can enhance its e-commerce platform and digital marketing efforts to drive online sales. By optimizing its website for search engines and investing in targeted advertising campaigns, MCOA can attract more customers and increase conversion rates. The company can also leverage social media platforms to engage with customers and build brand awareness. These digital strategies can be implemented within the next 6-12 months, leading to increased online sales and customer engagement.
Development of Proprietary Formulations and Intellectual Property: MCOA can invest in research and development to create proprietary formulations and intellectual property for its products. By developing unique and differentiated products, MCOA can establish a competitive advantage and protect its market share. The company can also seek patents for its formulations and technologies, further strengthening its intellectual property portfolio. This long-term strategy can enhance MCOA's brand reputation and attract investors.

Market capitalization of $0.00B indicates a micro-cap company with limited financial resources.
P/E ratio of -0.09 reflects negative earnings and challenges in achieving profitability.
Profit margin of -1441.1% highlights significant losses and operational inefficiencies.
Gross margin of -74.1% indicates that the cost of goods sold exceeds revenue, posing a substantial challenge to the company's business model.
Beta of 9.91 suggests extreme volatility compared to the broader market, making it a high-risk investment.

MCOA提供哪些产品和服务？

Develops and produces cannabis and cannabidiol (CBD) products.
Distributes products under the hempSMART brand.
Offers hempSMART Brain for brain wellness.
Provides hempSMART Pain capsules and cream for discomfort relief.
Sells hempSMART Drops, a hemp CBD oil tincture.
Markets hempSMART Pet Drops for cats and dogs.
Offers hempSMART Face, a facial moisturizer.
Distributes hemp and CBD products through www.cdistro.com.

MCOA如何赚钱？

Develops and manufactures hempSMART branded CBD and cannabis products.
Sells products directly to consumers through its website.
Distributes products through affiliate marketing programs.
Wholesales hemp and CBD products to retailers via cdistro.com.

Individual consumers seeking wellness and pain relief products.
Retailers, including smoke shops, vape shops, and c-stores.
Wholesalers distributing hemp and CBD products.
Affiliate marketers promoting hempSMART products.

Brand recognition of hempSMART products.
Proprietary formulations, including hempSMART Brain.
Established distribution network through cdistro.com.
Affiliate marketing program driving sales.

什么因素可能推动MCOA股价上涨？

Upcoming: Potential legalization of cannabis at the federal level in the U.S., which could significantly expand the market for MCOA's products.
Ongoing: Expansion of the hempSMART product line to include new formulations and delivery methods.
Ongoing: Strategic partnerships and distribution agreements to increase market reach.
Ongoing: Enhanced e-commerce and digital marketing efforts to drive online sales.
Ongoing: International expansion into legal cannabis markets.

MCOA的主要风险是什么？

Ongoing: Intense competition in the cannabis and CBD market, which could erode MCOA's market share.
Potential: Complex and evolving regulatory landscape, which could impact MCOA's ability to operate and sell its products.
Potential: Fluctuations in consumer demand for cannabis and CBD products.
Potential: Potential for product recalls or safety concerns, which could damage MCOA's brand reputation.
Ongoing: Negative profitability and gross margins, which could threaten MCOA's financial sustainability.

MCOA的核心优势是什么？

Established hempSMART brand.
Proprietary formulations like hempSMART Brain.
Distribution network through cdistro.com.
Direct-to-consumer sales channel.

MCOA的劣势是什么？

Negative profitability and gross margins.
High beta indicating extreme volatility.
Limited financial resources.
Small employee base.

MCOA有哪些机遇？

Expansion of hempSMART product line.
Strategic partnerships and distribution agreements.
International expansion into legal cannabis markets.
Enhanced e-commerce and digital marketing efforts.

MCOA面临哪些威胁？

Intense competition in the cannabis and CBD market.
Complex and evolving regulatory landscape.
Fluctuations in consumer demand.
Potential for product recalls or safety concerns.

MCOA的竞争对手是谁？

Body and Mind Inc. — Focuses on vertically integrated cannabis operations. — (BHHKF)
Compass Diversified Holdings — Diversified holding company with cannabis interests. — (CPMD)
iAnthus Capital Holdings, Inc. — Operates cannabis cultivation and retail facilities. — (ISCNF)
MedMen Enterprises Inc. — Cannabis retailer with a focus on premium products. — (MNFSF)
Newstrike Brands Ltd. — Canadian cannabis producer. — (NOBDF)

Key Metrics

MoonshotScore: 42/100

Company Profile

CEO: Jesus Quintero
Headquarters: Los Angeles, US
Employees: 7
Founded: 1999

AI Insight

AI analysis pending for MCOA

OTC Tier: OTC Other
Disclosure Status: Unknown

常见问题

What does Marijuana Company of America, Inc. do?

Marijuana Company of America, Inc. (MCOA) develops, produces, and distributes cannabis and cannabidiol (CBD) products under the hempSMART brand. The company's product line includes personal care products, pain relief capsules and creams, CBD oil tinctures, pet products, and drink mixes. These products are sold through the company's website, affiliate marketing programs, and wholesale distribution channels. MCOA aims to capitalize on the growing demand for CBD and cannabis-based wellness products in the United States and potentially international markets.

What do analysts say about MCOA stock?

As of 2026-03-17, there is no available analyst coverage for Marijuana Company of America, Inc. due to its OTC listing and small market capitalization. Key valuation metrics such as P/E ratio (-0.09), profit margin (-1441.1%), and gross margin (-74.1%) indicate significant financial challenges. Potential investors should conduct their own thorough due diligence and consider the risks associated with investing in OTC-listed companies with limited financial information.

What are the main risks for MCOA?

The main risks for Marijuana Company of America, Inc. include intense competition in the cannabis and CBD market, complex and evolving regulations, fluctuations in consumer demand, and potential product recalls. The company's negative profitability and gross margins pose a significant threat to its financial sustainability. Additionally, its OTC listing and limited financial disclosure increase the risk of fraud or manipulation. Investors should carefully consider these risks before investing in MCOA.